Kathleen OLoughlin - Feb 8, 2022 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Kathleen T. O'Loughlin
Stock symbol
BIOL
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 02:03 PM
Previous filing
Aug 26, 2021
Next filing
May 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +90K $0.00 90K Feb 8, 2022 Common Stock 90K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award fully vests and is immediately exercisable on March 31, 2024.